中国处方药
中國處方藥
중국처방약
CHINA PRESCRIPTION DRUG
2014年
7期
20-21
,共2页
左炔诺孕酮宫内节育系统%屈螺酮炔雌醇片%阴道不规则出血%痛经%满意度
左炔諾孕酮宮內節育繫統%屈螺酮炔雌醇片%陰道不規則齣血%痛經%滿意度
좌결낙잉동궁내절육계통%굴라동결자순편%음도불규칙출혈%통경%만의도
Mirena%Drospirenone Ethinylestradiol Tablets%Irregular vaginal bleeding%Dysmenorrhea%Satisfaction%Clinical practice
目的：分析屈螺酮炔雌醇片在左炔诺孕酮宫内节育系统放置后预防治疗阴道不规则出血的临床效果。方法将2011年10月～2013年10月接诊的160例放置左炔诺孕酮宫内节育系统的患者作为研究对象，随机均分为研究组与对照组，各自80例，其中研究组在放置左炔诺孕酮宫内节育系统后随即口服屈螺酮炔雌醇片治疗，而对照组则不给予屈螺酮炔雌醇片。对两组患者放置左炔诺孕酮宫内节育系统后随访3个月，并在随访第1、2、3个月时观察记录患者阴道不规则出血及痛经缓解情况，并对比分析两组患者相关指标。结果两组患者随访3个月期间，研究组阴道不规则出血总发生率明显低于对照组，满意率明显优于对照组，组间对比差异有统计学意义（P＜0.05）；两组患者在痛经缓解率上并无显著性差异。结论患者放置左炔诺孕酮宫内节育系统后口服屈螺酮炔雌醇片可以缓解患者痛经发生率，同时降低阴道不规则出血发生率，提高患者满意度，值得借鉴。
目的：分析屈螺酮炔雌醇片在左炔諾孕酮宮內節育繫統放置後預防治療陰道不規則齣血的臨床效果。方法將2011年10月～2013年10月接診的160例放置左炔諾孕酮宮內節育繫統的患者作為研究對象，隨機均分為研究組與對照組，各自80例，其中研究組在放置左炔諾孕酮宮內節育繫統後隨即口服屈螺酮炔雌醇片治療，而對照組則不給予屈螺酮炔雌醇片。對兩組患者放置左炔諾孕酮宮內節育繫統後隨訪3箇月，併在隨訪第1、2、3箇月時觀察記錄患者陰道不規則齣血及痛經緩解情況，併對比分析兩組患者相關指標。結果兩組患者隨訪3箇月期間，研究組陰道不規則齣血總髮生率明顯低于對照組，滿意率明顯優于對照組，組間對比差異有統計學意義（P＜0.05）；兩組患者在痛經緩解率上併無顯著性差異。結論患者放置左炔諾孕酮宮內節育繫統後口服屈螺酮炔雌醇片可以緩解患者痛經髮生率，同時降低陰道不規則齣血髮生率，提高患者滿意度，值得藉鑒。
목적：분석굴라동결자순편재좌결낙잉동궁내절육계통방치후예방치료음도불규칙출혈적림상효과。방법장2011년10월～2013년10월접진적160례방치좌결낙잉동궁내절육계통적환자작위연구대상，수궤균분위연구조여대조조，각자80례，기중연구조재방치좌결낙잉동궁내절육계통후수즉구복굴라동결자순편치료，이대조조칙불급여굴라동결자순편。대량조환자방치좌결낙잉동궁내절육계통후수방3개월，병재수방제1、2、3개월시관찰기록환자음도불규칙출혈급통경완해정황，병대비분석량조환자상관지표。결과량조환자수방3개월기간，연구조음도불규칙출혈총발생솔명현저우대조조，만의솔명현우우대조조，조간대비차이유통계학의의（P＜0.05）；량조환자재통경완해솔상병무현저성차이。결론환자방치좌결낙잉동궁내절육계통후구복굴라동결자순편가이완해환자통경발생솔，동시강저음도불규칙출혈발생솔，제고환자만의도，치득차감。
Objective To analyze the clinical effect of drospirenone Ethinylestradiol Tablets Mirena placed in prevention and treatment of vaginal irregular bleeding after the.Methods In our hospital from October 2011 to October 2013, 160 patients with Mirena as the research object, randomly divided into study group and control group, each 80 cases, the research group in the Mirena immediately after the oral Qu Luo ketone Ethinylestradiol Tablets treatment, while the control group was not given Qu Luo ketone Ethinylestradiol Tablets. 3 months of follow-up of two groups of patients with Mirena, and in the follow-up of first, 2, and 3 months were observed vaginal irregular bleeding and pain relief, and comparative analysis of relevant indicators of two groups of patients.Results The two groups during the follow-up period of three months, the study group irregular vaginal bleeding incidence was significantly lower than the control group, the satisfactory rate was significantly better than the control group, the difference was statistically significant between group comparison(P<0.05); the two group patients in remission rate was no significant difference in dysmenorrhea . Conclusion Mirena patients subsequently oral drospirenone Ethinylestradiol Tablets cansignificantly relieve the patients incidence of dysmenorrhea, irregular vaginal bleeding and reduce the incidence rate, improve patient satisfaction, worthy of reference.
